Southern Research

Southern Research is a contract research organization dedicated to translating breakthrough discoveries into practical, life-changing solutions. The organization provides comprehensive preclinical and clinical research capabilities spanning discovery through clinical implementation.

Therapeutic Areas

• Infectious Disease Research
• Oncology
• Emerging & Rare Disease Initiatives

Core Capabilities

• Chemistry & Drug Discovery: Chemistry services, high-throughput screening (HTS), medicinal chemistry support
• ADME & Toxicology: ADME and in vitro toxicology, safety pharmacology
• Bioanalytical Services: Advanced bioanalytical labs for clinical trial sample analysis
• In Vivo Models & Pharmacology: In vivo efficacy and PK/PD studies, toxicology and pharmacology services, specialized animal models
• Pathology: Histopathology and pathology services
• Biosafety Level 3 (BSL-3) Services: Specialized BSL-3 facilities for infectious disease research
• Clinical Services: Clinical trial sample analysis and support

Strategic Partnerships

Leverages a strategic affiliation with the University of Alabama at Birmingham (UAB) to accelerate cutting-edge research and innovation. The organization also operates Station 41, which accelerates biotechnology startups through laboratory space and mentorship, and Catalyst, a statewide personalized medicine research initiative.